Physician profile

Alison R Wright

Family Medicine · Lafayette, IN

NPI 1043305279

$4,772.95

in general payments reported to CMS, 2019-2025

40 companies · $245 in 2025

The $245 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$934.19

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Novo Nordisk INC $721.37 2019-2025 Rybelsus, Ozempic
Astrazeneca Pharmaceuticals LP $396.49 2019-2021
Glaxosmithkline, LLC. $377.50 2019-2023 Shingrix, Arexvy
Amgen INC. $352.44 2019-2021
Abbvie INC. $310.39 2021-2024
Lilly USA, LLC $299.58 2019-2021
Pfizer INC. $278.14 2019-2021
Janssen Pharmaceuticals, INC $271.72 2019-2023 Xarelto
Abbott Laboratories $261.59 2022-2025 Freestyle Libre 3
Dexcom, INC. $209.41 2021-2025 Dexcom G6 Transmitter
Merck Sharp & Dohme LLC $205.08 2019-2025 Gardasil 9, Gardasil, Capvaxive
Exact Sciences Corporation $181.75 2023-2025 Cologuard Collection Kit
Boehringer Ingelheim Pharmaceuticals, INC. $95.30 2020-2021
Bayer Healthcare Pharmaceuticals INC. $69.77 2019-2021
Medtronic, INC. $62.87 2024-2025 Kyphon Express II Kyphopak Tray, Intellis Adaptivestim
Show all 40 companies
CompanyGeneral paymentsYearsTop products
Allergan, INC. $56.97 2019-2020
Biohaven Pharmaceuticals, INC. $56.50 2021
Astellas Pharma US INC $50.61 2019-2021
Grifols USA, LLC $44.75 2023 Prolastin-C Liquid, Hyperrab
Clarus Therapeutics INC. $44.38 2021
Takeda Pharmaceuticals U.S.A., INC. $41.95 2021
Ironshore Pharmaceuticals INC. $39.45 2019
Boston Scientific Corporation $32.46 2024
Amarin Pharma, INC. $29.41 2020-2021
Novartis Pharmaceuticals Corporation $28.71 2019-2021
Sanofi-Aventis U.S. LLC $25.18 2019
Jazz Pharmaceuticals INC. $24.42 2021
Mannkind Corporation $22.09 2023 Afrezza
Upsher-Smith Laboratories LLC $20.34 2019
Bausch & Lomb Americas INC. $19.86 2024 Vyzulta
Genzyme Corporation $16.48 2019
Insulet Corporation $16.13 2023 Omnipod
Agile Therapeutics, INC. $15.01 2021
Tactile Systems Technology INC $14.62 2024 Flexitouch Plus, Entre Plus
Shire North American Group INC $14.56 2019
Sanofi Pasteur INC. $14.30 2019
Biogen, INC. $14.09 2021
Circassia INC. $13.06 2019
Eisai INC. $12.41 2020
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $11.81 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Alison R Wright

$4,772.95

in general payments reported 2019-2025

Years
2019-2025
Top company
Novo Nordisk INC
Context
The $245 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).

https://glasscript.com/doctor/137570/alison-r-wright

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.